Moderna, Inc. Business Operations Contracts & Agreements
10 Contracts & Agreements
- Collaboration Agreements (2 contracts)
- Development Agreements (6)
- Indemnification Agreements (1)
- Sales Agreements (1)
- Amendment No. 13 to Agreement No. HHSO100201600029C, by and between ModernaTX, Inc. and the Biomedical Advanced Research and Development Authority, dated as of March 23, 2022 (Filed With SEC on August 3, 2022)
- Amendment No. 12 to Agreement No. HHSO100201600029C, by and between ModernaTX, Inc. and the Biomedical Advanced Research and Development Authority, dated as of March 23, 2022 (Filed With SEC on May 4, 2022)
- Amendment No. 11 to Agreement No. HHSO100201600029C, by and between ModernaTX, Inc. and the Biomedical Advanced Research and Development Authority, dated as of November 4, 2021 (Filed With SEC on February 25, 2022)
- Amendment No. 7, dated March 12, 2021, to Agreement No. HHSO100201600029C, by and between ModernaTX, Inc. and the Biomedical Advanced Research and Development Authority, dated as... (Filed With SEC on May 6, 2021)
- Global Long Term Agreement, by and among ModernaTX Inc., Lonza Sales Ltd., and Lonza Ltd., dated September 4, 2020 (Filed With SEC on October 30, 2020)
- Agreement No. HHSO100201600029C, by and between the Company and the Biomedical Advanced Research and Development Authority, dated as of April 16, 2020, as amended on May 24, 2020,... (Filed With SEC on October 30, 2020)
- Agreement No. HHSO100201600029C, by and between the Company and the Biomedical Advanced Research and Development Authority, dated as of April 16, 2020, as amended (Filed With SEC on August 6, 2020)
- Fifth Amendment to Collaboration and License Agreement by and between ModernaTX, Inc. and Merck Sharp & Dohme Corp., dated as of May 3, 2019 (Filed With SEC on August 8, 2019)
- Master Collaboration and License Agreement, by and between Moderna Therapeutics, Inc. and Merck Sharp & Dohme Corp., dated as of January 12, 2015, as amended by Amendment No. 1... (Filed With SEC on November 9, 2018)
- Form of Indemnification Agreement between the Registrant and each of its directors (Filed With SEC on November 9, 2018)
